Dysport® is a newer competitor of Botox®, distributed by McKesson – the same company that distributes the popular dermal filler Restylane®. Dysport® was approved for use by the FDA in 2009, however, it has been available in Europe and other countries since 1990. Dysport® is very similar to Botox® but there are some slight differences that may make it a preferred choice in the reduction and elimination of facial wrinkles.
Dysport® is administered in exactly the same way as Botox® – via injection with a very fine needle into facial muscles. However, as with all injectables, the injection technique and skill level of the provider is as critical as the product itself to ensure the best final result. Your provider must also be aware of the subtle differences between the two products to ensure they use correct injection technique. For example, Botox® and Dysport® are not dose-equivalent products and require the provider to understand the standard dosing equivalent ratio to ensure a correct and safe dose of each product is used.
Read more